Model
Edge
Alnylam Pharmaceuticals, Inc.
0001219016
Filing type
144
Filing date
Aug 17, 2025
Updated
Aug 18, 2025 ยท 2:08 PM
Copy reference
Filing
144
Notice of Proposed Sale of Securities